{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T17:46:36Z","timestamp":1778953596552,"version":"3.51.4"},"reference-count":126,"publisher":"Bentham Science Publishers Ltd.","issue":"11","funder":[{"DOI":"10.13039\/501100004564","name":"Ministry of Science, Education and Technological Development, Republic of Serbia","doi-asserted-by":"publisher","award":["173033"],"award-info":[{"award-number":["173033"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2020,7,17]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Gastroesophageal Reflux Disease (GERD) is characterized by acid and bile reflux in the distal\noesophagus, and this may cause the development of reflux esophagitis and Barrett\u2019s oesophagus\n(BE). The natural histological course of untreated BE is non-dysplastic or benign BE (ND), then lowgrade\n(LGD) and High-Grade Dysplastic (HGD) BE, with the expected increase in malignancy transfer\nto oesophagal adenocarcinoma (EAC). The gold standard for BE diagnostics involves high-resolution\nwhite-light endoscopy, followed by uniform endoscopy findings description (Prague classification)\nwith biopsy performance according to Seattle protocol. The medical treatment of GERD and BE\nincludes the use of proton pump inhibitors (PPIs) regarding symptoms control. It is noteworthy that\nlong-term use of PPIs increases gastrin level, which can contribute to transfer from BE to EAC, as a\nresult of its effects on the proliferation of BE epithelium. Endoscopy treatment includes a wide range\nof resection and ablative techniques, such as radio-frequency ablation (RFA), often concomitantly used\nin everyday endoscopy practice (multimodal therapy). RFA promotes mucosal necrosis of treated\noesophagal region via high-frequency energy. Laparoscopic surgery, partial or total fundoplication, is\nreserved for PPIs and endoscopy indolent patients or in those with progressive disease. This review\naims to explain distinct effects of PPIs and RFA modalities, illuminate certain aspects of molecular\nmechanisms involved, as well as the effects of their concomitant use regarding the treatment of BE and\nprevention of its transfer to EAC.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389557519666191015203636","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T16:05:50Z","timestamp":1571846750000},"page":"975-987","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Proton Pump Inhibitors and Radiofrequency Ablation for Treatment of Barrett's Esophagus"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0890-021X","authenticated-orcid":true,"given":"Predrag","family":"Dugalic","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, University Clinical-Hospital Centre Zemun-Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srdjan","family":"Djuranovic","sequence":"additional","affiliation":[{"name":"Clinical Centre of Serbia, Clinic for Gastroenterology and Hepatology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Pavlovic-Markovic","sequence":"additional","affiliation":[{"name":"Clinical Centre of Serbia, Clinic for Gastroenterology and Hepatology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Dugalic","sequence":"additional","affiliation":[{"name":"Clinical Centre of Serbia, Clinic for Surgery, Faculty of Medicine, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9691-3167","authenticated-orcid":true,"given":"Ratko","family":"Tomasevic","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Faculty of Medicine, University of Belgrade, University Clinical-Hospital Centre Zemun-Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6371-6610","authenticated-orcid":true,"given":"Zoran","family":"Gluvic","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Faculty of Medicine, University of Belgrade, University Clinical-Hospital Centre Zemun-Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4769-2652","authenticated-orcid":true,"given":"Milan","family":"Obradovic","sequence":"additional","affiliation":[{"name":"Department of Radiobiology and Molecular Genetics, Institute of Nuclear Sciences Vinca, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2333-8245","authenticated-orcid":true,"given":"Vladan","family":"Bajic","sequence":"additional","affiliation":[{"name":"Department of Radiobiology and Molecular Genetics, Institute of Nuclear Sciences Vinca, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0012-2636","authenticated-orcid":true,"given":"Esma R.","family":"Isenovic","sequence":"additional","affiliation":[{"name":"Department of Radiobiology and Molecular Genetics, Institute of Nuclear Sciences Vinca, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/bjs.18003815005","volume":"38","author":"Barrett N.R.","year":"1950","unstructured":"Barrett N.R.; Chronic peptic ulcer of the oesophagus and \u2018oesophagitis\u2019. Br J Surg 1950,38(150),175-182","journal-title":"Br J Surg"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","volume":"63","author":"El-Serag H.B.","year":"2014","unstructured":"El-Serag H.B.; Sweet S.; Winchester C.C.; Dent J.; Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2014,63(6),871-880","journal-title":"Gut"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1038\/ajg.2010.194","volume":"105","author":"Taylor J.B.","year":"2010","unstructured":"Taylor J.B.; Rubenstein J.H.; Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett\u2019s esophagus. Am J Gastroenterol 2010,105(8),1729-1730","journal-title":"Am J Gastroenterol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1136\/gut.2007.145177","volume":"57","author":"Zagari R.M.","year":"2008","unstructured":"Zagari R.M.; Fuccio L.; Wallander M.A.; Johansson S.; Fiocca R.; Casanova S.; Farahmand B.Y.; Winchester C.C.; Roda E.; Bazzoli F.; Gastro-oesophageal reflux symptoms, oesophagitis and Barrett\u2019s oesophagus in the general population: the Loiano-Monghidoro study. Gut 2008,57(10),1354-1359","journal-title":"Gut"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1053\/j.gastro.2005.08.053","volume":"129","author":"Ronkainen J.","year":"2005","unstructured":"Ronkainen J.; Aro P.; Storskrubb T.; Johansson S.E.; Lind T.; Bolling-Sternevald E.; Vieth M.; Stolte M.; Talley N.J.; Agr\u00e9us L.; Prevalence of Barrett\u2019s esophagus in the general population: an endoscopic study. Gastroenterology 2005,129(6),1825-1831","journal-title":"Gastroenterology"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.5694\/mja16.00796","volume":"205","author":"Whiteman D.C.","year":"2016","unstructured":"Whiteman D.C.; Kendall B.J.; Barrett\u2019s oesophagus: epidemiology, diagnosis and clinical management. Med J Aust 2016,205(7),317-324","journal-title":"Med J Aust"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1023\/B:DDAS.0000034549.55326.67","volume":"49","author":"Connor M.J.","year":"2004","unstructured":"Connor M.J.; Weston A.P.; Mayo M.S.; Sharma P.; The prevalence of Barrett\u2019s esophagus and erosive esophagitis in patients undergoing upper endoscopy for dyspepsia in a VA population. Dig Dis Sci 2004,49(6),920-924","journal-title":"Dig Dis Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1053\/j.gastro.2006.08.032","volume":"131","author":"Sharma P.","year":"2006","unstructured":"Sharma P.; Dent J.; Armstrong D.; Bergman J.J.; Gossner L.; Hoshihara Y.; Jankowski J.A.; Junghard O.; Lundell L.; Tytgat G.N.; Vieth M.; The development and validation of an endoscopic grading system for Barrett\u2019s esophagus: the Prague C","journal-title":"Gastroenterology"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1053\/j.gastro.2011.01.031","volume":"140","author":"Spechler S.J.","year":"2011","unstructured":"Spechler S.J.; Sharma P.; Souza R.F.; Inadomi J.M.; Shaheen N.J.; American Gastroenterological Association technical review on the management of Barrett\u2019s esophagus. Gastroenterology American Gastroenterological Association2011,140(3),e18-e52","journal-title":"Gastroenterology"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4292\/wjgpt.v7.i2.190","volume":"7","author":"Martinucci I.","year":"2016","unstructured":"Martinucci I.; de Bortoli N.; Russo S.; Bertani L.; Furnari M.; Mokrowiecka A.; Malecka-Panas E.; Savarino V.; Savarino E.; Marchi S.; Barrett\u2019s esophagus in 2016: From pathophysiology to treatment. World J Gastrointest Pharmacol Ther 2016,7(2),190-206","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/ajg.2015.322","volume":"111","author":"Shaheen N.J.","year":"2016","unstructured":"Shaheen N.J.; Falk G.W.; Iyer P.G.; Gerson L.B.; ACG Clinical Guideline: Diagnosis and Management of Barrett\u2019s Esophagus. Am J Gastroenterol American College of Gastroenterology2016,111(1),30-50","journal-title":"Am J Gastroenterol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1007\/s00464-015-4103-3","volume":"29","author":"Brown C.S.","year":"2015","unstructured":"Brown C.S.; Lapin B.; Wang C.; Goldstein J.L.; Linn J.G.; Denham W.; Haggerty S.P.; Talamonti M.S.; Howington J.A.; Carbray J.; Ujiki M.B.; Reflux control is important in the management of Barrett\u2019s Esophagus: results from a retrospective 1,830 patient cohort. Surg Endosc 2015,29(12),3528-3534","journal-title":"Surg Endosc"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5694\/j.1326-5377.2004.tb05991.x","volume":"180","author":"Hillman L.C.","year":"2004","unstructured":"Hillman L.C.; Chiragakis L.; Shadbolt B.; Kaye G.L.; Clarke A.C.; Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett\u2019s oesophagus. Med J Aust 2004,180(8),387-391","journal-title":"Med J Aust"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.cgh.2012.11.014","volume":"11","author":"Kastelein F.","year":"2013","unstructured":"Kastelein F.; Spaander M.C.; Steyerberg E.W.; Biermann K.; Valkhoff V.E.; Kuipers E.J.; Bruno M.J.; Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett\u2019s esophagus. Clin Gastroenterol Hepatol 2013,11(4),382-388","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/gast.2003.50008","volume":"124","author":"Corley D.A.","year":"2003","unstructured":"Corley D.A.; Kerlikowske K.; Verma R.; Buffler P.; Protective association of aspirin\/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 2003,124(1),47-56","journal-title":"Gastroenterology"},{"key":"ref=16","year":"2010","unstructured":"Epithelial radiofrequency ablation for Barrett's oesophagus. Interventional procedures guidance [IPG344] National Institute for Health and Clinical Excellence2010","journal-title":"Interventional procedures guidance [IPG344]"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/gastro\/got015","volume":"1","author":"Sappati Biyyani R.S.","year":"2013","unstructured":"Sappati Biyyani R.S.; Chak A.; Barrett\u2019s esophagus: review of diagnosis and treatment. Gastroenterol Rep (Oxf) 2013,1(1),9-18","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1053\/j.gastro.2012.04.032","volume":"143","author":"Bennett C.","year":"2012","unstructured":"Bennett C.; Vakil N.; Bergman J.; Harrison R.; Odze R.; Vieth M.; Sanders S.; Gay L.; Pech O.; Longcroft-Wheaton G.; Romero Y.; Inadomi J.; Tack J.; Corley D.A.; Manner H.; Green S.; Al Dulaimi D.; Ali H.; Allum B.; Anderson M.; Curtis H.; Falk G.; Fennerty M.B.; Fullarton G.; Krishnadath K.; Meltzer S.J.; Armstrong D.; Ganz R.; Cengia G.; Going J.J.; Goldblum J.; Gordon C.; Grabsch H.; Haigh C.; Hongo M.; Johnston D.; Forbes-Young R.; Kay E.; Kaye P.; Lerut T.; Lovat L.B.; Lundell L.; Mairs P.; Shimoda T.; Spechler S.; Sontag S.; Malfertheiner P.; Murray I.; Nanji M.; Poller D.; Ragunath K.; Regula J.; Cestari R.; Shepherd N.; Singh R.; Stein H.J.; Talley N.J.; Galmiche J.P.; Tham T.C.; Watson P.; Yerian L.; Rugge M.; Rice T.W.; Hart J.; Gittens S.; Hewin D.; Hochberger J.; Kahrilas P.; Preston S.; Sampliner R.; Sharma P.; Stuart R.; Wang K.; Waxman I.; Abley C.; Loft D.; Penman I.; Shaheen N.J.; Chak A.; Davies G.; Dunn L.; Falck-Ytter Y.; Decaestecker J.; Bhandari P.; Ell C.; Griffin S.M.; Attwood S.; Barr H.; Allen J.; Ferguson M.K.; Moayyedi P.; Jankowski J.A.; Consensus statements for management of Barrett\u2019s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2012,143(2),336-346","journal-title":"Gastroenterology"},{"key":"ref=19","first-page":"449","volume":"12","author":"Falk G.W.","year":"2016","unstructured":"Falk G.W.; Updated Guidelines for Diagnosing and Managing Barrett Esophagus. Gastroenterol Hepatol (N Y) 2016,12(7),449-451","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1001\/jama.2011.626","volume":"305","author":"Galmiche J.P.","year":"2011","unstructured":"Galmiche J.P.; Hatlebakk J.; Attwood S.; Ell C.; Fiocca R.; Eklund S.; L\u00e5ngstr\u00f6m G.; Lind T.; Lundell L.; Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA LOTUS Trial Collaborators2011,305(19),1969-1977","journal-title":"JAMA"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.3748\/wjg.v23.i28.5051","volume":"23","author":"Amadi C.","year":"2017","unstructured":"Amadi C.; Gatenby P.; Barrett\u2019s oesophagus: Current controversies. World J Gastroenterol 2017,23(28),5051-5067","journal-title":"World J Gastroenterol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/ajg.2013.72","volume":"108","author":"Thrift A.P.","year":"2013","unstructured":"Thrift A.P.; Kramer J.R.; Qureshi Z.; Richardson P.A.; El-Serag H.B.; Age at onset of GERD symptoms predicts risk of Barrett\u2019s esophagus. Am J Gastroenterol 2013,108(6),915-922","journal-title":"Am J Gastroenterol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/gut.51.3.323","volume":"51","author":"Chak A.","year":"2002","unstructured":"Chak A.; Lee T.; Kinnard M.F.; Brock W.; Faulx A.; Willis J.; Cooper G.S.; Sivak M.V.; Goddard K.A.; Familial aggregation of Barrett\u2019s oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut 2002,51(3),323-328","journal-title":"Gut"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1572-0241.2005.40187.x","volume":"100","author":"van Blankenstein M.","year":"2005","unstructured":"van Blankenstein M.; Looman C.W.; Johnston B.J.; Caygill C.P.; Age and sex distribution of the prevalence of Barrett\u2019s esophagus found in a primary referral endoscopy center. Am J Gastroenterol 2005,100(3),568-576","journal-title":"Am J Gastroenterol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.gtc.2015.02.001","volume":"44","author":"Runge T.M.","year":"2015","unstructured":"Runge T.M.; Abrams J.A.; Shaheen N.J.; Epidemiology of Barrett\u2019s esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am 2015,44(2),203-231","journal-title":"Gastroenterol Clin North Am"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1136\/gut.2008.163360","volume":"58","author":"Corley D.A.","year":"2009","unstructured":"Corley D.A.; Kubo A.; Levin T.R.; Block G.; Habel L.; Rumore G.; Quesenberry C.; Buffler P.; Race, ethnicity, sex and temporal differences in Barrett\u2019s oesophagus diagnosis: a large community-based study, 1994-2006. Gut 2009,58(2),182-188","journal-title":"Gut"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/aje\/kwi325","volume":"162","author":"Cook M.B.","year":"2005","unstructured":"Cook M.B.; Wild C.P.; Forman D.; A systematic review and meta-analysis of the sex ratio for Barrett\u2019s esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol 2005,162(11),1050-1061","journal-title":"Am J Epidemiol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1111\/jgh.12230","volume":"28","author":"Andrici J.","year":"2013","unstructured":"Andrici J.; Cox M.R.; Eslick G.D.; Cigarette smoking and the risk of Barrett\u2019s esophagus: a systematic review and meta-analysis. J Gastroenterol Hepatol 2013,28(8),1258-1273","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1053\/j.gastro.2011.12.049","volume":"142","author":"Cook M.B.","year":"2012","unstructured":"Cook M.B.; Shaheen N.J.; Anderson L.A.; Giffen C.; Chow W.H.; Vaughan T.L.; Whiteman D.C.; Corley D.A.; Cigarette smoking increases risk of Barrett\u2019s esophagus: an analysis of the Barrett\u2019s and Esophageal Adenocarcinoma Consortium. Gastroenterology 2012,142(4),744-753","journal-title":"Gastroenterology"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/ijc.27887","volume":"132","author":"Kendall B.J.","year":"2013","unstructured":"Kendall B.J.; Macdonald G.A.; Hayward N.K.; Prins J.B.; O\u2019Brien S.; Whiteman D.C.; The risk of Barrett\u2019s esophagus associated with abdominal obesity in males and females. Int J Cancer Study of Digestive Health2013,132(9),2192-2199","journal-title":"Int J Cancer"},{"key":"ref=31","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju252","volume":"106","author":"Thrift A.P.","year":"2014","unstructured":"Thrift A.P.; Shaheen N.J.; Gammon M.D.; Bernstein L.; Reid B.J.; Onstad L.; Risch H.A.; Liu G.; Bird N.C.; Wu A.H.; Corley D.A.; Romero Y.; Chanock S.J.; Chow W.H.; Casson A.G.; Levine D.M.; Zhang R.; Ek W.E.; MacGregor S.; Ye W.; Hardie L.J.; Vaughan T.L.; Whiteman D.C.; Obesity and risk of esophageal adenocarcinoma and Barrett\u2019s esophagus: a Mendelian randomization study. J Natl Cancer Inst 2014,106(11)","journal-title":"J Natl Cancer Inst"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.mayocp.2012.09.017","volume":"88","author":"Leggett C.L.","year":"2013","unstructured":"Leggett C.L.; Nelsen E.M.; Tian J.; Schleck C.B.; Zinsmeister A.R.; Dunagan K.T.; Locke G.R.; Wang K.K.; Talley N.J.; Iyer P.G.; Metabolic syndrome as a risk factor for Barrett esophagus: a population-based case-control study. Mayo Clin Proc 2013,88(2),157-165","journal-title":"Mayo Clin Proc"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.cgh.2013.03.024","volume":"11","author":"Iyer P.G.","year":"2013","unstructured":"Iyer P.G.; Borah B.J.; Heien H.C.; Das A.; Cooper G.S.; Chak A.; Association of Barrett\u2019s esophagus with type II Diabetes Mellitus: results from a large population-based case-control study. Clin Gastroenterol Hepatol 2013,11(9),1108-1114.e5","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cgh.2013.08.043","volume":"12","author":"Leggett C.L.","year":"2014","unstructured":"Leggett C.L.; Gorospe E.C.; Calvin A.D.; Harmsen W.S.; Zinsmeister A.R.; Caples S.; Somers V.K.; Dunagan K.; Lutzke L.; Wang K.K.; Iyer P.G.; Obstructive sleep apnea is a risk factor for Barrett\u2019s esophagus. Clin Gastroenterol Hepatol 2014,12(4),583-8.e1","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/gutjnl-2011-300641","volume":"61","author":"Greer K.B.","year":"2012","unstructured":"Greer K.B.; Thompson C.L.; Brenner L.; Bednarchik B.; Dawson D.; Willis J.; Grady W.M.; Falk G.W.; Cooper G.S.; Li L.; Chak A.; Association of insulin and insulin-like growth factors with Barrett\u2019s oesophagus. Gut 2012,61(5),665-672","journal-title":"Gut"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/gut.2007.131243","volume":"57","author":"Kendall B.J.","year":"2008","unstructured":"Kendall B.J.; Macdonald G.A.; Hayward N.K.; Prins J.B.; Brown I.; Walker N.; Pandeya N.; Green A.C.; Webb P.M.; Whiteman D.C.; Leptin and the risk of Barrett\u2019s oesophagus. Gut Study of Digestive Health2008,57(4),448-454","journal-title":"Gut"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/gut.2007.132068","volume":"57","author":"Corley D.A.","year":"2008","unstructured":"Corley D.A.; Kubo A.; Levin T.R.; Block G.; Habel L.; Zhao W.; Leighton P.; Rumore G.; Quesenberry C.; Buffler P.; Parsonnet J.; Helicobacter pylori infection and the risk of Barrett\u2019s oesophagus: a community-based study. Gut 2008,57(6),727-733","journal-title":"Gut"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1002\/ijc.26242","volume":"130","author":"Thrift A.P.","year":"2012","unstructured":"Thrift A.P.; Pandeya N.; Smith K.J.; Green A.C.; Hayward N.K.; Webb P.M.; Whiteman D.C.; Helicobacter pylori infection and the risks of Barrett\u2019s oesophagus: a population-based case-control study. Int J Cancer 2012,130(10),2407-2416","journal-title":"Int J Cancer"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/gut.2007.131672","volume":"57","author":"Francois F.","year":"2008","unstructured":"Francois F.; Roper J.; Goodman A.J.; Pei Z.; Ghumman M.; Mourad M.; de Perez A.Z.; Perez-Perez G.I.; Tseng C.H.; Blaser M.J.; The association of gastric leptin with oesophageal inflammation and metaplasia. Gut 2008,57(1),16-24","journal-title":"Gut"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/gut.52.5.637","volume":"52","author":"Nwokolo C.U.","year":"2003","unstructured":"Nwokolo C.U.; Freshwater D.A.; O\u2019Hare P.; Randeva H.S.; Plasma ghrelin following cure of Helicobacter pylori. Gut 2003,52(5),637-640","journal-title":"Gut"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s10620-018-5161-x","volume":"63","author":"Kuipers E.J.","year":"2018","unstructured":"Kuipers E.J.; Spaander M.C.; Natural History of Barrett\u2019s Esophagus. Dig Dis Sci 2018,63(8),1997-2004","journal-title":"Dig Dis Sci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/00365521.2010.521888","volume":"46","author":"Zou D.","year":"2011","unstructured":"Zou D.; He J.; Ma X.; Chen J.; Gong Y.; Man X.; Gao L.; Wang R.; Zhao Y.; Yan X.; Liu W.; Wernersson B.; Johansson S.; Dent J.; Sung J.J.; Li Z.; Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: the systematic investigation of gastrointestinal diseases in China (SILC). Scand J Gastroenterol 2011,46(2),133-141","journal-title":"Scand J Gastroenterol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.cgh.2015.07.050","volume":"13","author":"Shiota S.","year":"2015","unstructured":"Shiota S.; Singh S.; Anshasi A.; El-Serag H.B.; Prevalence of Barrett\u2019s Esophagus in asian countries: A systematic review and meta-analysis. Clin Gastroenterol Hepatol 2015,13(11),1907-1918","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1586\/egh.10.82","volume":"5","author":"Fock K.M.","year":"2011","unstructured":"Fock K.M.; Ang T.L.; Global epidemiology of Barrett\u2019s esophagus. Expert Rev Gastroenterol Hepatol 2011,5(1),123-130","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nrgastro.2014.181","volume":"12","author":"McDonald S.A.","year":"2015","unstructured":"McDonald S.A.; Lavery D.; Wright N.A.; Jansen M.; Barrett oesophagus: lessons on its origins from the lesion itself. Nat Rev Gastroenterol Hepatol 2015,12(1),50-60","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.cell.2011.05.026","volume":"145","author":"Wang X.","year":"2011","unstructured":"Wang X.; Ouyang H.; Yamamoto Y.; Kumar P.A.; Wei T.S.; Dagher R.; Vincent M.; Lu X.; Bellizzi A.M.; Ho K.Y.; Crum C.P.; Xian W.; McKeon F.; Residual embryonic cells as precursors of a Barrett\u2019s-like metaplasia. Cell 2011,145(7),1023-1035","journal-title":"Cell"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ccr.2011.12.004","volume":"21","author":"Quante M.","year":"2012","unstructured":"Quante M.; Bhagat G.; Abrams J.A.; Marache F.; Good P.; Lee M.D.; Lee Y.; Friedman R.; Asfaha S.; Dubeykovskaya Z.; Mahmood U.; Figueiredo J.L.; Kitajewski J.; Shawber C.; Lightdale C.J.; Rustgi A.K.; Wang T.C.; Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell 2012,21(1),36-51","journal-title":"Cancer Cell"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature24269","volume":"550","author":"Jiang M.","year":"2017","unstructured":"Jiang M.; Li H.; Zhang Y.; Yang Y.; Lu R.; Liu K.; Lin S.; Lan X.; Wang H.; Wu H.; Zhu J.; Zhou Z.; Xu J.; Lee D.K.; Zhang L.; Lee Y.C.; Yuan J.; Abrams J.A.; Wang T.C.; Sepulveda A.R.; Wu Q.; Chen H.; Sun X.; She J.; Chen X.; Que J.; Transitional basal cells at the squamous-columnar junction generate Barrett\u2019s oesophagus. Nature 2017,550(7677),529-533","journal-title":"Nature"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/nyas.13909","volume":"1434","author":"Inadomi J.","year":"2018","unstructured":"Inadomi J.; Alastal H.; Bonavina L.; Gross S.; Hunt R.H.; Mashimo H.; di Pietro M.; Rhee H.; Shah M.; Tolone S.; Wang D.H.; Xie S.H.; Recent advances in Barrett\u2019s esophagus. Ann N Y Acad Sci 2018,1434(1),227-238","journal-title":"Ann N Y Acad Sci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"10380","DOI":"10.1038\/ncomms10380","volume":"7","author":"Yamamoto Y.","year":"2016","unstructured":"Yamamoto Y.; Wang X.; Bertrand D.; Kern F.; Zhang T.; Duleba M.; Srivastava S.; Khor C.C.; Hu Y.; Wilson L.H.; Blaszyk H.; Rolshud D.; Teh M.; Liu J.; Howitt B.E.; Vincent M.; Crum C.P.; Nagarajan N.; Ho K.Y.; McKeon F.; Xian W.; Mutational spectrum of Barrett\u2019s stem cells suggests paths to initiation of a precancerous lesion. Nat Commun 2016,7,10380","journal-title":"Nat Commun"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1053\/j.gastro.2009.07.055","volume":"137","author":"Souza R.F.","year":"2009","unstructured":"Souza R.F.; Huo X.; Mittal V.; Schuler C.M.; Carmack S.W.; Zhang H.Y.; Zhang X.; Yu C.; Hormi-Carver K.; Genta R.M.; Spechler S.J.; Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 2009,137(5),1776-1784","journal-title":"Gastroenterology"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1001\/jama.2016.5657","volume":"315","author":"Dunbar K.B.","year":"2016","unstructured":"Dunbar K.B.; Agoston A.T.; Odze R.D.; Huo X.; Pham T.H.; Cipher D.J.; Castell D.O.; Genta R.M.; Souza R.F.; Spechler S.J.; Association of acute gastroesophageal reflux disease with esophageal histologic changes. JAMA 2016,315(19),2104-2112","journal-title":"JAMA"},{"key":"ref=53","first-page":"1854","volume":"63","author":"Lavery D.L.","year":"2014","unstructured":"Lavery D.L.; Nicholson A.M.; Poulsom R.;  The stem cell organisation,\nand the proliferative and gene expression profile of Barrett's\nepithelium, replicates pyloric-type gastric glands 2014,63(12),1854-1863","journal-title":"The stem cell organisation,\nand the proliferative and gene expression profile of Barrett's\nepithelium, replicates pyloric-type gastric glands"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/ng.3357","volume":"47","author":"Ross-Innes C.S.","year":"2015","unstructured":"Ross-Innes C.S.; Becq J.; Warren A.; Cheetham R.K.; Northen H.; O\u2019Donovan M.; Malhotra S.; di Pietro M.; Ivakhno S.; He M.; Weaver J.M.J.; Lynch A.G.; Kingsbury Z.; Ross M.; Humphray S.; Bentley D.; Fitzgerald R.C.; Whole-genome sequencing provides new insights into the clonal architecture of Barrett\u2019s esophagus and esophageal adenocarcinoma. Nat Genet 2015,47(9),1038-1046","journal-title":"Nat Genet"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/dote.12015","volume":"26","author":"Timmer M.R.","year":"2013","unstructured":"Timmer M.R.; Sun G.; Gorospe E.C.; Leggett C.L.; Lutzke L.; Krishnadath K.K.; Wang K.K.; Predictive biomarkers for Barrett\u2019s esophagus: so near and yet so far. Dis Esophagus 2013,26(6),574-581","journal-title":"Dis Esophagus"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1007\/s10620-018-5088-2","volume":"63","author":"Konda V.J.A.","year":"2018","unstructured":"Konda V.J.A.; Souza R.F.; Biomarkers of Barrett\u2019s Esophagus: From the Laboratory to Clinical Practice. Dig Dis Sci 2018,63(8),2070-2080","journal-title":"Dig Dis Sci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/jgh.12913","volume":"30","author":"Whiteman D.C.","year":"2015","unstructured":"Whiteman D.C.; Appleyard M.; Bahin F.F.; Bobryshev Y.V.; Bourke M.J.; Brown I.; Chung A.; Clouston A.; Dickins E.; Emery J.; Eslick G.D.; Gordon L.G.; Grimpen F.; Hebbard G.; Holliday L.; Hourigan L.F.; Kendall B.J.; Lee E.Y.; Levert-Mignon A.; Lord R.V.; Lord S.J.; Maule D.; Moss A.; Norton I.; Olver I.; Pavey D.; Raftopoulos S.; Rajendra S.; Schoeman M.; Singh R.; Sitas F.; Smithers B.M.; Taylor A.C.; Thomas M.L.; Thomson I.; To H.; von Dincklage J.; Vuletich C.; Watson D.I.; Yusoff I.F.; Australian clinical practice guidelines for the diagnosis and management of Barrett\u2019s esophagus and early esophageal adenocarcinoma. J Gastroenterol Hepatol 2015,30(5),804-820","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1053\/j.gastro.2011.01.031","volume":"140","author":"Spechler S.J.","year":"2011","unstructured":"Spechler S.J.; Sharma P.; Souza R.F.; Inadomi J.M.; Shaheen N.J.; American Gastroenterological Association medical position statement on the management of Barrett\u2019s esophagus. Gastroenterology American Gastroenterological Association2011,140(3),1084-1091","journal-title":"Gastroenterology"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/j.1572-0241.2007.01230.x","volume":"102","author":"Harrison R.","year":"2007","unstructured":"Harrison R.; Perry I.; Haddadin W.; McDonald S.; Bryan R.; Abrams K.; Sampliner R.; Talley N.J.; Moayyedi P.; Jankowski J.A.; Detection of intestinal metaplasia in Barrett\u2019s esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol 2007,102(6),1154-1161","journal-title":"Am J Gastroenterol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0046-8177(88)80344-7","volume":"19","author":"Reid B.J.","year":"1988","unstructured":"Reid B.J.; Haggitt R.C.; Rubin C.E.; Roth G.; Surawicz C.M.; Van Belle G.; Lewin K.; Weinstein W.M.; Antonioli D.A.; Goldman H.; Observer variation in the diagnosis of dysplasia in Barrett\u2019s esophagus. Hum Pathol 1988,19(2),166-178","journal-title":"Hum Pathol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.anndiagpath.2018.09.013","volume":"37","author":"Montgomery E.","year":"2018","unstructured":"Montgomery E.; Arnold C.A.; Lam-Himlin D.; Salimian K.; Waters K.; Some observations on Barrett esophagus and associated dysplasia. Ann Diagn Pathol 2018,37,75-82","journal-title":"Ann Diagn Pathol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1007\/s10620-009-0951-9","volume":"54","author":"Kedika R.R.","year":"2009","unstructured":"Kedika R.R.; Souza R.F.; Spechler S.J.; Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci 2009,54(11),2312-2317","journal-title":"Dig Dis Sci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/ajg.2015.55","volume":"110","author":"Bennett C.","year":"2015","unstructured":"Bennett C.; Moayyedi P.; Corley D.A.; DeCaestecker J.; Falck-Ytter Y.; Falk G.; Vakil N.; Sanders S.; Vieth M.; Inadomi J.; Aldulaimi D.; Ho K.Y.; Odze R.; Meltzer S.J.; Quigley E.; Gittens S.; Watson P.; Zaninotto G.; Iyer P.G.; Alexandre L.; Ang Y.; Callaghan J.; Harrison R.; Singh R.; Bhandari P.; Bisschops R.; Geramizadeh B.; Kaye P.; Krishnadath S.; Fennerty M.B.; Manner H.; Nason K.S.; Pech O.; Konda V.; Ragunath K.; Rahman I.; Romero Y.; Sampliner R.; Siersema P.D.; Tack J.; Tham T.C.; Trudgill N.; Weinberg D.S.; Wang J.; Wang K.; Wong J.Y.; Attwood S.; Malfertheiner P.; MacDonald D.; Barr H.; Ferguson M.K.; Jankowski J.; BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett\u2019s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol BOB CAT Consortium2015,110(5),662-682","journal-title":"Am J Gastroenterol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.gie.2012.08.004","volume":"76","author":"Evans J.A.","year":"2012","unstructured":"Evans J.A.; Early D.S.; Fukami N.; Ben-Menachem T.; Chandrasekhara V.; Chathadi K.V.; Decker G.A.; Fanelli R.D.; Fisher D.A.; Foley K.Q.; Hwang J.H.; Jain R.; Jue T.L.; Khan K.M.; Lightdale J.; Malpas P.M.; Maple J.T.; Pasha S.F.; Saltzman J.R.; Sharaf R.N.; Shergill A.; Dominitz J.A.; Cash B.D.; The role of endoscopy in Barrett\u2019s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc ASGE Standards of Practice Committee; Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy2012,76(6),1087-1094","journal-title":"Gastrointest Endosc"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.cgh.2017.11.044","volume":"16","author":"Krishnamoorthi R.","year":"2018","unstructured":"Krishnamoorthi R.; Singh S.; Ragunathan K.; Visrodia K.; Wang K.K.; Katzka D.A.; Iyer P.G.; Factors Associated With Progression of Barrett\u2019s Esophagus: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2018,16(7),1046-1055.e8","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1053\/j.gastro.2015.07.009","volume":"149","author":"Nguyen T.","year":"2015","unstructured":"Nguyen T.; Duan Z.; Naik A.D.; Kramer J.R.; El-Serag H.B.; Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett\u2019s esophagus: a nested case-control study. Gastroenterology 2015,149(6),1392-1398","journal-title":"Gastroenterology"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"67","DOI":"10.21037\/tgh.2018.09.10","volume":"3","author":"Triadafilopoulos G.","year":"2018","unstructured":"Triadafilopoulos G.; Friedland S.; Precision care for Barrett\u2019s esophagus. Transl Gastroenterol Hepatol 2018,3,67","journal-title":"Transl Gastroenterol Hepatol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-3-540-69297-3_15","volume":"181","author":"Das D.","year":"2009","unstructured":"Das D.; Chilton A.P.; Jankowski J.A.; Chemoprevention of oesophageal cancer and the AspECT trial. Recent Results Cancer Res 2009,181,161-169","journal-title":"Recent Results Cancer Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1053\/j.gastro.2010.02.045","volume":"138","author":"Nguyen D.M.","year":"2010","unstructured":"Nguyen D.M.; Richardson P.; El-Serag H.B.; Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett\u2019s esophagus. Gastroenterology 2010,138(7),2260-2266","journal-title":"Gastroenterology"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1749-6632.2011.06048.x","volume":"1232","author":"Richter J.E.","year":"2011","unstructured":"Richter J.E.; Penagini R.; Tenca A.; Pohl D.; Dvorak K.; Goldman A.; Savarino E.; Zentilin P.; Savarino V.; Watson J.T.; Wong R.K.; Pace F.; Casini V.; Peura D.A.; Herzig S.J.; Kamiya T.; Pelosini I.; Scarpignato C.; Armstrong D.; DeVault K.R.; Bechi P.; Taddei A.; Freschi G.; Ringressi M.N.; Degli\u2019Innocenti D.R.; Castiglione F.; Masini E.; Hunt R.H.; Barrett\u2019s esophagus: proton pump inhibitors and chemoprevention II. Ann N Y Acad Sci 2011,1232,114-139","journal-title":"Ann N Y Acad Sci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2013-305372","volume":"63","author":"Fitzgerald R.C.","year":"2014","unstructured":"Fitzgerald R.C.; di Pietro M.; Ragunath K.; Ang Y.; Kang J.Y.; Watson P.; Trudgill N.; Patel P.; Kaye P.V.; Sanders S.; O\u2019Donovan M.; Bird-Lieberman E.; Bhandari P.; Jankowski J.A.; Attwood S.; Parsons S.L.; Loft D.; Lagergren J.; Moayyedi P.; Lyratzopoulos G.; de Caestecker J.; British Society of Gastroenterology guidelines on the diagnosis and management of Barrett\u2019s oesophagus. Gut British Society of Gastroenterology2014,63(1),7-42","journal-title":"Gut"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3889\/oamjms.2018.232","volume":"6","author":"Gashi Z.","year":"2018","unstructured":"Gashi Z.; Bahtiri E.; Gashi A.; Sherifi F.; Proton pump inhibitors diminish Barrett\u2019s Esophagus length: Our experience. Open Access Maced J Med Sci 2018,6(6),1041-1045","journal-title":"Open Access Maced J Med Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fonc.2014.00373","volume":"4","author":"Alsalahi O.","year":"2015","unstructured":"Alsalahi O.; Dobrian A.D.; Proton pump inhibitors: The culprit for Barrett\u2019s Esophagus? Front Oncol 2015,4,373","journal-title":"Front Oncol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5009\/gnl15502","volume":"11","author":"Strand D.S.","year":"2017","unstructured":"Strand D.S.; Kim D.; Peura D.A.; 25 years of proton pump inhibitors: A comprehensive review. Gut Liver 2017,11(1),27-37","journal-title":"Gut Liver"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1124\/dmd.113.051722","volume":"41","author":"Shirasaka Y.","year":"2013","unstructured":"Shirasaka Y.; Sager J.E.; Lutz J.D.; Davis C.; Isoherranen N.; Inhibition of CYP2C19 and CYP3A4 by omeprazole metabolites and their contribution to drug-drug interactions. Drug Metab Dispos 2013,41(7),1414-1424","journal-title":"Drug Metab Dispos"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1365-2036.2006.02943.x","volume":"23","author":"Sachs G.","year":"2006","unstructured":"Sachs G.; Shin J.M.; Howden C.W.; Review article: the clinical pharmacology of proton pump inhibitors. Aliment Pharmacol Ther 2006,23(Suppl. 2),2-8","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1586\/egh.12.18","volume":"6","author":"Marelli S.","year":"2012","unstructured":"Marelli S.; Pace F.; Rabeprazole for the treatment of acid-related disorders. Expert Rev Gastroenterol Hepatol 2012,6(4),423-435","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cgh.2011.11.021","volume":"10","author":"Fass R.","year":"2012","unstructured":"Fass R.; Inadomi J.; Han C.; Mody R.; O\u2019Neil J.; Perez M.C.; Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release. Clin Gastroenterol Hepatol 2012,10(3),247-253","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1023\/A:1015009300955","volume":"47","author":"R\u00f6hss K.","year":"2002","unstructured":"R\u00f6hss K.; Hasselgren G.; Hedenstr\u00f6m H.; Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease. Dig Dis Sci 2002,47(5),954-958","journal-title":"Dig Dis Sci"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1586\/ecp.09.33","volume":"2","author":"Shin J.M.","year":"2009","unstructured":"Shin J.M.; Sachs G.; Long lasting inhibitors of the gastric H,K-ATPase. Expert Rev Clin Pharmacol 2009,2(5),461-468","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1053\/gast.2001.28649","volume":"121","author":"Inadomi J.M.","year":"2001","unstructured":"Inadomi J.M.; Jamal R.; Murata G.H.; Hoffman R.M.; Lavezo L.A.; Vigil J.M.; Swanson K.M.; Sonnenberg A.; Step-down management of gastroesophageal reflux disease. Gastroenterology 2001,121(5),1095-1100","journal-title":"Gastroenterology"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1136\/gut.2005.087668","volume":"55","author":"Mainie I.","year":"2006","unstructured":"Mainie I.; Tutuian R.; Shay S.; Vela M.; Zhang X.; Sifrim D.; Castell D.O.; Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006,55(10),1398-1402","journal-title":"Gut"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.med.46.1.395","volume":"46","author":"Meko J.B.","year":"1995","unstructured":"Meko J.B.; Norton J.A.; Management of patients with Zollinger-Ellison syndrome. Annu Rev Med 1995,46,395-411","journal-title":"Annu Rev Med"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2036.2005.02553.x","volume":"22","author":"Sj\u00f6stedt S.","year":"2005","unstructured":"Sj\u00f6stedt S.; Befrits R.; Sylvan A.; Harthon C.; J\u00f6rgensen L.; Carling L.; Modin S.; Stubber\u00f6d A.; Toth E.; Lind T.; Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis. Aliment Pharmacol Ther 2005,22(3),183-191","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=85","doi-asserted-by":"publisher","DOI":"10.1159\/isbn.978-3-318-02416-6","author":"Chiba T.","year":"2013","unstructured":"Chiba T.; Malfertheiner P.; Satoh H.;  Proton Pump Inhibitors: A Balanced View, Frontiers of Gastrointestinal ResearchM Frontiers of Gastrointestinal Research: Karger2013","journal-title":"Proton Pump Inhibitors: A Balanced View, Frontiers of Gastrointestinal ResearchM"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"S226","DOI":"10.1097\/MCG.0b013e31803233b7","volume":"41","author":"Sachs G.","year":"2007","unstructured":"Sachs G.; Shin J.M.; Vagin O.; Lambrecht N.; Yakubov I.; Munson K.; The gastric H,K ATPase as a drug target: past, present, and future. J Clin Gastroenterol 2007,41(Suppl. 2),S226-S242","journal-title":"J Clin Gastroenterol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"29617","DOI":"10.1074\/jbc.R100023200","volume":"276","author":"Dunbar L.A.","year":"2001","unstructured":"Dunbar L.A.; Caplan M.J.; Ion pumps in polarized cells: sorting and regulation of the Na+, K+- and H+, K+-ATPases. J Biol Chem 2001,276(32),29617-29620","journal-title":"J Biol Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1016\/j.febslet.2010.04.035","volume":"584","author":"Poulsen H.","year":"2010","unstructured":"Poulsen H.; Morth P.; Egebjerg J.; Nissen P.; Phosphorylation of the Na+,K+-ATPase and the H+,K+-ATPase. FEBS Lett 2010,584(12),2589-2595","journal-title":"FEBS Lett"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/978-3-319-21756-7_13","volume":"16","author":"Sakai H.","year":"2016","unstructured":"Sakai H.; Fujii T.; Takeguchi N.; Proton-Potassium (H(+)\/K(+)) ATPases: Properties and roles in health and diseases. Met Ions Life Sci 2016,16,459-483","journal-title":"Met Ions Life Sci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00424-008-0495-4","volume":"457","author":"Shin J.M.","year":"2009","unstructured":"Shin J.M.; Munson K.; Vagin O.; Sachs G.; The gastric HK-ATPase: structure, function, and inhibition. Pflugers Arch 2009,457(3),609-622","journal-title":"Pflugers Arch"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00228-008-0538-y","volume":"64","author":"Shi S.","year":"2008","unstructured":"Shi S.; Klotz U.; Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol 2008,64(10),935-951","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/02652048.2018.1515997","volume":"35","author":"Kim J.S.","year":"2018","unstructured":"Kim J.S.; Park J.H.; Jeong S.C.; Kim D.S.; Yousaf A.M.; Din F.U.; Kim J.O.; Yong C.S.; Youn Y.S.; Oh K.T.; Jin S.G.; Choi H.G.; Novel revaprazan-loaded gelatin microsphere with enhanced drug solubility and oral bioavailability. J Microencapsul 2018,35(5),421-427","journal-title":"J Microencapsul"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/0091270003261321","volume":"44","author":"Yu K.S.","year":"2004","unstructured":"Yu K.S.; Bae K.S.; Shon J.H.; Cho J.Y.; Yi S.Y.; Chung J.Y.; Lim H.S.; Jang I.J.; Shin S.G.; Song K.S.; Moon B.S.; Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers. J Clin Pharmacol 2004,44(1),73-82","journal-title":"J Clin Pharmacol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pharmthera.2016.08.001","volume":"168","author":"Inatomi N.","year":"2016","unstructured":"Inatomi N.; Matsukawa J.; Sakurai Y.; Otake K.; Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases. Pharmacol Ther 2016,168,12-22","journal-title":"Pharmacol Ther"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1572-0241.2008.01790.x","volume":"103","author":"Das D.","year":"2008","unstructured":"Das D.; Ishaq S.; Harrison R.; Kosuri K.; Harper E.; Decaestecker J.; Sampliner R.; Attwood S.; Barr H.; Watson P.; Moayyedi P.; Jankowski J.; Management of Barrett\u2019s esophagus in the UK: overtreated and underbiopsied but improved by the introduction of a national randomized trial. Am J Gastroenterol 2008,103(5),1079-1089","journal-title":"Am J Gastroenterol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1365-2125.2006.02687.x","volume":"62","author":"Trifir\u00f2 G.","year":"2006","unstructured":"Trifir\u00f2 G.; Corrao S.; Alacqua M.; Moretti S.; Tari M.; Caputi A.P.; Arcoraci V.; Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources. Br J Clin Pharmacol UVEC Group2006,62(5),582-590","journal-title":"Br J Clin Pharmacol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"6418","DOI":"10.1182\/blood-2011-04-350082","volume":"118","author":"Krieg L.","year":"2011","unstructured":"Krieg L.; Milstein O.; Krebs P.; Xia Y.; Beutler B.; Du X.; Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice. Blood 2011,118(24),6418-6425","journal-title":"Blood"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.mayocp.2017.10.022","volume":"93","author":"Nehra A.K.","year":"2018","unstructured":"Nehra A.K.; Alexander J.A.; Loftus C.G.; Nehra V.; Proton pump inhibitors: Review of emerging concerns. Mayo Clin Proc 2018,93(2),240-246","journal-title":"Mayo Clin Proc"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1021\/cn500103u","volume":"5","author":"Fawaz M.V.","year":"2014","unstructured":"Fawaz M.V.; Brooks A.F.; Rodnick M.E.; Carpenter G.M.; Shao X.; Desmond T.J.; Sherman P.; Quesada C.A.; Hockley B.G.; Kilbourn M.R.; Albin R.L.; Frey K.A.; Scott P.J.; High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer\u2019s disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection. ACS Chem Neurosci 2014,5(8),718-730","journal-title":"ACS Chem Neurosci"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","volume":"73","author":"Gomm W.","year":"2016","unstructured":"Gomm W.; von Holt K.; Thom\u00e9 F.; Broich K.; Maier W.; Fink A.; Doblhammer G.; Haenisch B.; Association of proton pump inhibitors with risk of dementia: A pharmacoepidemiological claims data analysis. JAMA Neurol 2016,73(4),410-416","journal-title":"JAMA Neurol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3233\/JAD-2010-1262","volume":"19","author":"Rojo L.E.","year":"2010","unstructured":"Rojo L.E.; Alzate-Morales J.; Saavedra I.N.; Davies P.; Maccioni R.B.; Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer\u2019s disease. J Alzheimers Dis 2010,19(2),573-589","journal-title":"J Alzheimers Dis"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"12524","DOI":"10.1073\/pnas.0903328106","volume":"106","author":"Carmona M.A.","year":"2009","unstructured":"Carmona M.A.; Murai K.K.; Wang L.; Roberts A.J.; Pasquale E.B.; Glial ephrin-A3 regulates hippocampal dendritic spine morphology and glutamate transport. Proc Natl Acad Sci USA 2009,106(30),12524-12529","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fncel.2015.00278","volume":"9","author":"Ben Haim L.","year":"2015","unstructured":"Ben Haim L.; Carrillo-de Sauvage M.A.; Ceyz\u00e9riat K.; Escartin C.; Elusive roles for reactive astrocytes in neurodegenerative diseases. Front Cell Neurosci 2015,9,278","journal-title":"Front Cell Neurosci"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(18)31388-6","volume":"392","author":"Jankowski J.A.Z.","year":"2018","unstructured":"Jankowski J.A.Z.; de Caestecker J.; Love S.B.; Reilly G.; Watson P.; Sanders S.; Ang Y.; Morris D.; Bhandari P.; Brooks C.; Attwood S.; Harrison R.; Barr H.; Moayyedi P.; Esomeprazole and aspirin in Barrett\u2019s oesophagus (AspECT): a randomised factorial trial. Lancet AspECT Trial Team2018,392(10145),400-408","journal-title":"Lancet"},{"key":"ref=105","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doy004","volume":"31","author":"Harrison M.","year":"2018","unstructured":"Harrison M.; Allen J.E.; Gorrepati V.S.; L\u00f3pez-Jamar J.M.E.; Sharma P.; Management of Barrett\u2019s esophagus with low-grade dysplasia. Dis Esophagus 2018,31(4)","journal-title":"Dis Esophagus"},{"key":"ref=106","first-page":"366","volume":"73","author":"Krajciova J.","year":"2018","unstructured":"Krajciova J.; Vackova Z.; Spicak J.; Martinek J.; Radiofrequency ablation for Barrett\u2019s esophagus-related neoplasia. Minerva Chir 2018,73(4),366-377","journal-title":"Minerva Chir"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.bpg.2014.11.007","volume":"29","author":"Blevins C.H.","year":"2015","unstructured":"Blevins C.H.; Iyer P.G.; Endoscopic therapy for Barrett\u2019s oesophagus. Best Pract Res Clin Gastroenterol 2015,29(1),167-177","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1080\/00365520601075803","volume":"42","author":"Pech O.","year":"2007","unstructured":"Pech O.; Vieth M.; Schmitz D.; Gossner L.; May A.; Seitz G.; Stolte M.; Ell C.; Conclusions from the histological diagnosis of low-grade intraepithelial neoplasia in Barrett\u2019s oesophagus. Scand J Gastroenterol 2007,42(6),682-688","journal-title":"Scand J Gastroenterol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1053\/j.gastro.2015.04.013","volume":"149","author":"Small A.J.","year":"2015","unstructured":"Small A.J.; Araujo J.L.; Leggett C.L.; Mendelson A.H.; Agarwalla A.; Abrams J.A.; Lightdale C.J.; Wang T.C.; Iyer P.G.; Wang K.K.; Rustgi A.K.; Ginsberg G.G.; Forde K.A.; Gimotty P.A.; Lewis J.D.; Falk G.W.; Bewtra M.; Radiofrequency ablation is associated with decreased neoplastic progression in patients with Barrett\u2019s Esophagus and confirmed Low-Grade dysplasia. Gastroenterology 2015,149(3),567-76.e3","journal-title":"Gastroenterology"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0042-122140","volume":"49","author":"Weusten B.","year":"2017","unstructured":"Weusten B.; Bisschops R.; Coron E.; Dinis-Ribeiro M.; Dumonceau J.M.; Esteban J.M.; Hassan C.; Pech O.; Repici A.; Bergman J.; di Pietro M.; Endoscopic management of Barrett\u2019s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy 2017,49(2),191-198","journal-title":"Endoscopy"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ajg.2009.88","volume":"104","author":"Pouw R.E.","year":"2009","unstructured":"Pouw R.E.; Gondrie J.J.; Rygiel A.M.; Sondermeijer C.M.; ten Kate F.J.; Odze R.D.; Vieth M.; Krishnadath K.K.; Bergman J.J.; Properties of the neosquamous epithelium after radiofrequency ablation of Barrett\u2019s esophagus containing neoplasia. Am J Gastroenterol 2009,104(6),1366-1373","journal-title":"Am J Gastroenterol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.thorsurg.2013.07.010","volume":"23","author":"Davila M.L.","year":"2013","unstructured":"Davila M.L.; Hofstetter W.L.; Endoscopic management of Barrett\u2019s esophagus with high-grade dysplasia and early-stage esophageal adenocarcinoma. Thorac Surg Clin 2013,23(4),479-489","journal-title":"Thorac Surg Clin"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1055\/s-0034-1391436","volume":"47","author":"K\u00fcnzli H.T.","year":"2015","unstructured":"K\u00fcnzli H.T.; Sch\u00f6lvinck D.W.; Phoa K.N.; Schoon E.J.; Houben M.H.; Bergman J.J.; Weusten B.L.; Simplified protocol for focal radiofrequency ablation using the HALO90 device: short-term efficacy and safety in patients with dysplastic Barrett\u2019s esophagus. Endoscopy 2015,47(7),592-597","journal-title":"Endoscopy"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cgh.2009.07.003","volume":"8","author":"Pouw R.E.","year":"2010","unstructured":"Pouw R.E.; Wirths K.; Eisendrath P.; Sondermeijer C.M.; Ten Kate F.J.; Fockens P.; Devi\u00e8re J.; Neuhaus H.; Bergman J.J.; Efficacy of radiofrequency ablation combined with endoscopic resection for barrett\u2019s esophagus with early neoplasia. Clin Gastroenterol Hepatol 2010,8(1),23-29","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.gie.2013.02.002","volume":"78","author":"van Vilsteren F.G.","year":"2013","unstructured":"van Vilsteren F.G.; Phoa K.N.; Alvarez Herrero L.; Pouw R.E.; Sondermeijer C.M.; Visser M.; Ten Kate F.J.; van Berge Henegouwen M.I.; Weusten B.L.; Schoon E.J.; Bergman J.J.; A simplified regimen for focal radiofrequency ablation of Barrett\u2019s mucosa: a randomized multicenter trial comparing two ablation regimens. Gastrointest Endosc 2013,78(1),30-38","journal-title":"Gastrointest Endosc"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S2468-1253(18)30157-2","volume":"3","author":"Pouw R.E.","year":"2018","unstructured":"Pouw R.E.; K\u00fcnzli H.T.; Bisschops R.; Sondermeijer C.M.; Koch A.D.; Didden P.; Gotink A.W.; Schoon E.J.; Curvers W.L.; Bergman J.J.G.H.M.; Weusten B.L.A.M.; Simplified versus standard regimen for focal radiofrequency ablation of dysplastic Barrett\u2019s oesophagus: a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol 2018,3(8),566-574","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/jama.2014.2511","volume":"311","author":"Phoa K.N.","year":"2014","unstructured":"Phoa K.N.; van Vilsteren F.G.; Weusten B.L.; Bisschops R.; Schoon E.J.; Ragunath K.; Fullarton G.; Di Pietro M.; Ravi N.; Visser M.; Offerhaus G.J.; Seldenrijk C.A.; Meijer S.L.; ten Kate F.J.; Tijssen J.G.; Bergman J.J.; Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA 2014,311(12),1209-1217","journal-title":"JAMA"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa0808145","volume":"360","author":"Shaheen N.J.","year":"2009","unstructured":"Shaheen N.J.; Sharma P.; Overholt B.F.; Wolfsen H.C.; Sampliner R.E.; Wang K.K.; Galanko J.A.; Bronner M.P.; Goldblum J.R.; Bennett A.E.; Jobe B.A.; Eisen G.M.; Fennerty M.B.; Hunter J.G.; Fleischer D.E.; Sharma V.K.; Hawes R.H.; Hoffman B.J.; Rothstein R.I.; Gordon S.R.; Mashimo H.; Chang K.J.; Muthusamy V.R.; Edmundowicz S.A.; Spechler S.J.; Siddiqui A.A.; Souza R.F.; Infantolino A.; Falk G.W.; Kimmey M.B.; Madanick R.D.; Chak A.; Lightdale C.J.; Radiofrequency ablation in Barrett\u2019s esophagus with dysplasia. N Engl J Med 2009,360(22),2277-2288","journal-title":"N Engl J Med"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cgh.2012.10.028","volume":"11","author":"Bulsiewicz W.J.","year":"2013","unstructured":"Bulsiewicz W.J.; Kim H.P.; Dellon E.S.; Cotton C.C.; Pasricha S.; Madanick R.D.; Spacek M.B.; Bream S.E.; Chen X.; Orlando R.C.; Shaheen N.J.; Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett\u2019s esophagus. Clin Gastroenterol Hepatol 2013,11(6),636-642","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.tgie.2018.02.002","volume":"20","author":"Kumar S.","year":"2018","unstructured":"Kumar S.; Iyer P.G.; Endoscopic eradication therapy for Barrett\u2019s esophagus: Adverse outcomes, patient values, and cost-effectiveness. Tech Gastrointest Endosc 2018,20(2),75-81","journal-title":"Tech Gastrointest Endosc"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/j.cgh.2014.04.034","volume":"12","author":"Pasricha S.","year":"2014","unstructured":"Pasricha S.; Bulsiewicz W.J.; Hathorn K.E.; Komanduri S.; Muthusamy V.R.; Rothstein R.I.; Wolfsen H.C.; Lightdale C.J.; Overholt B.F.; Camara D.S.; Dellon E.S.; Lyday W.D.; Ertan A.; Chmielewski G.W.; Shaheen N.J.; Durability and predictors of successful radiofrequency ablation for Barrett\u2019s esophagus. Clin Gastroenterol Hepatol 2014,12(11),1840-1847","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cgh.2018.05.042","volume":"17","author":"Tan M.C.","year":"2019","unstructured":"Tan M.C.; Kanthasamy K.A.; Yeh A.G.; Kil D.; Pompeii L.; Yu X.; El-Serag H.B.; Thrift A.P.; Factors associated with recurrence of Barrett\u2019s Esophagus after radiofrequency ablation. Clin Gastroenterol Hepatol 2019,17(1),65-72.e5","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.gie.2014.06.023","volume":"80","author":"Timmer M.R.","year":"2014","unstructured":"Timmer M.R.; Brankley S.M.; Gorospe E.C.; Sun G.; Lutzke L.S.; Iyer P.G.; Halling K.C.; Krishnadath K.K.; Wang K.K.; Prediction of response to endoscopic therapy of Barrett\u2019s dysplasia by using genetic biomarkers. Gastrointest Endosc 2014,80(6),984-991","journal-title":"Gastrointest Endosc"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.gie.2011.06.040","volume":"75","author":"Gupta N.","year":"2012","unstructured":"Gupta N.; Mathur S.C.; Dumot J.A.; Singh V.; Gaddam S.; Wani S.B.; Bansal A.; Rastogi A.; Goldblum J.R.; Sharma P.; Adequacy of esophageal squamous mucosa specimens obtained during endoscopy: are standard biopsies sufficient for postablation surveillance in Barrett\u2019s esophagus? Gastrointest Endosc 2012,75(1),11-18","journal-title":"Gastrointest Endosc"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/ajg.2012.78","volume":"107","author":"Dunbar K.B.","year":"2012","unstructured":"Dunbar K.B.; Spechler S.J.; The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett\u2019s esophagus: a systematic review. Am J Gastroenterol 2012,107(6),850-862","journal-title":"Am J Gastroenterol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1002\/1097-0142(20000601)88:11<2429::AID-CNCR1>3.0.CO;2-H","volume":"88","author":"van Sandick J.W.","year":"2000","unstructured":"van Sandick J.W.; van Lanschot J.J.; ten Kate F.J.; Offerhaus G.J.; Fockens P.; Tytgat G.N.; Obertop H.; Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer 2000,88(11),2429-2437","journal-title":"Cancer"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/175718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T15:20:39Z","timestamp":1602084039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/175718\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":126,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,7,17]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557519666191015203636","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,17]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-04-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}